Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

In vivo PERTURB-Flow: high-throughput single-cell perturbation screening for macrophage target discovery

Objective

This project aims to deliver proof-of-concept for in vivo PERTURB-Flow, a breakthrough technology for the systematic discovery of therapeutic targets in macrophages. The proof-of-concept will focus on microglia, the brain’s resident macrophages, both in homeostatic and disease conditions. In parallel, we will engage industrial partners and perform business development, patent and freedom-to-operate analyses, laying the groundwork for valorization and spin-off development. Together, these activities will establish a powerful platform that may move the macrophage field beyond its current scarcity of targets, providing a scalable pipeline for in vivo–validated therapeutic discovery.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-POC

See all projects funded under this call

Host institution

VRIJE UNIVERSITEIT BRUSSEL
Net EU contribution
€ 150 000,00
Address
PLEINLAAN 2
1050 Bruxelles / Brussel
Belgium
Region
Région de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest Région de Bruxelles-Capitale/ Brussels Hoofdstedelijk Gewest Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)